Stage III Multiple Myeloma

Showing 1 - 25 of 53

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,

Active, not recruiting
  • Stage I Multiple Myeloma
  • +2 more
  • Chicago, Illinois
  • +4 more
Sep 3, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +88 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 14, 2021

Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,

Completed
  • Refractory Multiple Myeloma
  • +4 more
  • total marrow irradiation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Feb 25, 2021

Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Bronx, Manhasset, New York (aflibercept)

Terminated
  • Stage II Multiple Myeloma
  • Stage III Multiple Myeloma
  • aflibercept
  • Bronx, New York
  • +5 more
Jan 29, 2021

Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Hematopoietic/Lymphoid Cancer
  • +135 more
  • beclomethasone dipropionate
  • +4 more
  • Hackensack, New Jersey
  • +1 more
Feb 1, 2021

Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in

Completed
  • Acute Undifferentiated Leukemia
  • +63 more
  • total-body irradiation
  • +7 more
  • Seattle, Washington
  • +1 more
Jan 17, 2020

Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic

Completed
  • Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
  • +76 more
  • fludarabine phosphate
  • +6 more
  • Tucson, Arizona
  • +10 more
Jan 17, 2020

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +35 more
  • Duarte, California
  • +4 more
Dec 24, 2019

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Philadelphia (Bendamustine HCl,

Completed
  • Stage I Multiple Myeloma
  • +2 more
  • Bendamustine hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 27, 2019

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (autologous immunoglobulin

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • autologous immunoglobulin idiotype-KLH conjugate vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 2, 2019

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in New York (romiplostim)

Terminated
  • Refractory Multiple Myeloma
  • +4 more
  • romiplostim
  • New York, New York
    NYU Cancer Institute
Sep 13, 2018

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Los Angeles (dalteparin, lenalidomide,

Terminated
  • Stage I Multiple Myeloma
  • +2 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Nov 27, 2017

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (cyclophosphamide, pegylated

Terminated
  • Refractory Multiple Myeloma
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 7, 2017

Multiple Myeloma in Relapse, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Pittsburgh, Madison (bevacizumab,

Completed
  • Multiple Myeloma in Relapse
  • +2 more
  • bevacizumab
  • +2 more
  • Pittsburgh, Pennsylvania
  • +1 more
Aug 2, 2017

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (drug, biological, procedure)

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 16, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +82 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 26, 2017

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Columbus (cryotherapy, questionnaire

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • cryotherapy
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 23, 2017

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (clarithromycin, thalidomide,

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 22, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +178 more
  • fludarabine phosphate
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 17, 2017

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (lenalidomide)

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 19, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +96 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 10, 2017